Artificial Joints Market Size, Share and Growth Outlook, 2026

Artificial Joints Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Artificial Joints Market size is forecast to increase from $25.87 Billion in 2026 to $36.51 Billion in 2034 at a CAGR of 4.4% between 2026 and 2034.

The Artificial Joints market report provides detailed analysis and outlook of Artificial Joints segments including By Type (Cemented Joints, Cementless, Hybrid Fixation Joints), By Material Type (Ceramics, Alloys & Metals, Oxinium, Polymers & Polyethylene), By Application (Artificial Knee Joints, Artificial Hip Joints, Artificial Shoulder Joints, Small Joint Replacements ), By End-User (Hospitals and Trauma Centers, Orthopedic and Prosthetic Clinics, Ambulatory Surgical Centers, Rehabilitation Centers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Artificial Joints Industry Overview

Robotic-Assisted Joint Replacement Reshaping Orthopedic Surgery

The artificial joints industry is experiencing significant technological advancement as robotic-assisted surgical systems, smart implants, and next-generation implant materials transform orthopedic care. Rising demand for knee and hip replacement procedures, combined with the need for greater surgical precision and improved patient outcomes, is accelerating the adoption of advanced joint reconstruction technologies. Manufacturers are focusing on robotic guidance, personalized surgical planning, and data-driven implant positioning to enhance procedural accuracy and support long-term implant performance. These innovations are helping surgeons optimize alignment, improve joint functionality, and reduce variability in total joint arthroplasty procedures.

Expansion of Robotic Platforms and Surgical Navigation Systems

Robotics continues to be a major growth driver within the artificial joints market. At the AAOS Annual Meeting, Stryker showcased the Mako RPS, a handheld robotic power tool for total knee arthroplasty that combines the familiar feel of manual instruments with robotic precision. The system offers a compact solution for surgeons seeking greater procedural control while benefiting from advanced robotic assistance. Zimmer Biomet further expanded its robotics portfolio with the latest version of the ROSA® Knee System, incorporating OptimiZe™ technology for personalized surgical planning. The company also highlighted the TMINI® Miniature Robotic System, a handheld, wireless CT-based robotic platform designed to improve implant placement accuracy during knee replacement procedures.

Innovation in Implant Design and Advanced Materials

Artificial joint manufacturers are increasingly investing in advanced materials and manufacturing techniques to improve implant durability and biological integration. Stryker introduced Triathlon Gold, a knee implant technology that combines additive manufacturing with a titanium nitride surface engineered for enhanced scratch resistance and long-term durability. The system supports both cemented and cementless surgical workflows, reflecting growing demand for flexible implant solutions. Smith & Nephew is also advancing its orthopedic portfolio through the Landmark™ Knee System, specifically optimized for ambulatory surgical centers. The planned introduction of cementless and cemented versions reflects broader industry trends toward minimally invasive, outpatient-focused joint replacement procedures.

Smart Implants and Data-Driven Postoperative Care

The integration of digital technologies into orthopedic implants is creating new opportunities for patient monitoring and outcome optimization. Zimmer Biomet released updated clinical data for Persona IQ®, the first smart knee implant capable of collecting gait and range-of-motion metrics directly from the implanted joint. This technology enables continuous postoperative monitoring and supports data-driven rehabilitation strategies. In addition, Monogram Technologies received FDA 510(k) clearance for its CT-based semi-autonomous robotic technology for total knee arthroplasty, further strengthening the role of imaging-guided automation in orthopedic surgery. The convergence of robotics, connected implants, and advanced analytics is accelerating the evolution of artificial joints toward more personalized and intelligent musculoskeletal care solutions.

Artificial Joints Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Artificial Joints market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Zimmer Biomet Holdings, Inc., Stryker Corporation, DePuy Synthes (Johnson & Johnson), Smith + Nephew plc, Enovis Corporation (DJO Global), Medacta International SA, Wright Medical Group N.V. (Stryker), MicroPort Scientific Corporation, B. Braun Melsungen AG (Aesculap), Conformis, Inc.. The Artificial Joints market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Artificial Joints industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Artificial Joints Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Artificial Joints companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Artificial Joints markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Artificial Joints Market Competitive Benchmarking and Company Analysis

Leading companies in Artificial Joints industry include- Zimmer Biomet Holdings, Inc., Stryker Corporation, DePuy Synthes (Johnson & Johnson), Smith + Nephew plc, Enovis Corporation (DJO Global), Medacta International SA, Wright Medical Group N.V. (Stryker), MicroPort Scientific Corporation, B. Braun Melsungen AG (Aesculap), Conformis, Inc.. The Artificial Joints market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Artificial Joints Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Artificial Joints market remains one of the strongest-performing segments in the country.
The US Artificial Joints Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Artificial Joints market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Artificial Joints industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Artificial Joints markets

Canada's strong Artificial Joints sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Artificial Joints market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Artificial Joints Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Artificial Joints market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Artificial Joints population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Artificial Joints industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Artificial Joints market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Artificial Joints sales through 2034

France Artificial Joints companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Artificial Joints Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Artificial Joints distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Artificial Joints Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Artificial Joints market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Artificial Joints industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Artificial Joints industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Artificial Joints Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Artificial Joints market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Artificial Joints market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Artificial Joints Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Artificial Joints Market Segmentation

By Type
Cemented Joints
Cementless
Hybrid Fixation Joints
By Material Type
Ceramics
Alloys & Metals
Oxinium
Polymers & Polyethylene
By Application
Artificial Knee Joints
Artificial Hip Joints
Artificial Shoulder Joints
Small Joint Replacements
By End-User
Hospitals and Trauma Centers
Orthopedic and Prosthetic Clinics
Ambulatory Surgical Centers
Rehabilitation Centers

Top Companies in Artificial Joints Industry

Zimmer Biomet Holdings, Inc.
Stryker Corporation
DePuy Synthes (Johnson & Johnson)
Smith + Nephew plc
Enovis Corporation (DJO Global)
Medacta International SA
Wright Medical Group N.V. (Stryker)
MicroPort Scientific Corporation
B. Braun Melsungen AG (Aesculap)
Conformis, Inc.

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025